Salts of fingolimod

Details for Australian Patent Application No. 2009315735 (hide)

Owner Novartis AG

Inventors Mutz, Michael; Jordine, Guido

Agent Davies Collison Cave

Pub. Number AU-A-2009315735

PCT Pub. Number WO2010/055027

Priority 08168862.4 11.11.08 EP

Filing date 10 November 2009

Wipo publication date 20 May 2010

International Classifications

C07C 215/10 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07C 215/20 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 215/28 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 215/46 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/055027 Priority application(s): WO2010/055027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009315736-Crystalline forms of fingolimod HCL

2009315732-Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same